Analyst Research

Report Title Price
Provider: ValuEngine, Inc.
$25.00
Provider: Finlabo SIM Spa
$10.00
Provider: Reuters Investment Profile
$20.00
Provider: Reuters Investment Profile
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Bayer AG's Bayer HealthCare LLC To Acquire Conceptus, Inc


Monday, 29 Apr 2013 02:30am EDT 

Bayer HealthCare LLC announced that it has signed a merger agreement with Conceptus, Inc., the California-based developer of the Essure procedure, the non-surgical permanent birth control method, which is sold in the United States and other countries. Within the next ten business days, Bayer will launch a public tender offer to acquire all shares in Conceptus, Inc. The transaction values Conceptus, Inc. at approximately USD1.1 billion (approx. EUR852 million) representing USD31.00 per share in cash. Closing is subject to customary conditions, in particular anti-trust approval in the U.S., and is expected by mid-year 2013. Bayer HealthCare, is a subgroup of Bayer AG. 

Company Quote

132.98
1.38 +1.05%
21 Aug 2014